PeptideKey News

Petrelintide: Weight Loss at 10.7% — Zero Nausea Risk [2026]

Zealand Pharma petrelintide hit 10.7% weight loss, zero vomiting in Phase 2. ZUPREME-1 trial shows a GLP-1 alternative without the nausea problem.

Loading full content...